Pharmaceuticals

Pharmaceuticals Native Starch Market Analysis Covering Growth Drivers And Future Outlook

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Pharmaceuticals Native Starch Market From 2026 To 2030?

The pharmaceuticals native starch market has demonstrated robust expansion recently. This market is projected to expand from $6.11 billion in 2025 to $6.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. Historically, this growth can be attributed to factors such as the availability of natural starch sources, the increasing prevalence of generic pharmaceuticals, the extensive application of tablets and capsules, cost considerations in drug formulation, and the regulatory acceptance of native starch.

The pharmaceuticals native starch market is projected to experience substantial growth over the coming years, reaching a value of $9.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This anticipated expansion during the forecast period is driven by factors such as the rise of clean-label drug formulations, stricter sustainability mandates, the broadening of pharmaceutical manufacturing activities in developing markets, an increasing need for biodegradable excipients, and innovations in starch processing. Key developments expected during this timeframe include a heightened demand for natural and clean-label excipients, increased integration into solid oral dosage forms, growing utilization as both binders and disintegrants, the wider availability of plant-based pharmaceutical ingredients, and a greater emphasis on affordable excipients.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Drivers Are Supporting The Pharmaceuticals Native Starch Market Growth?

The increasing occurrence of chronic diseases is projected to stimulate the growth of the pharmaceuticals native starch market moving forward. Chronic diseases are enduring medical conditions that typically progress slowly and persist for a year or longer. The rising prevalence of these conditions is primarily linked to an aging population, as older individuals are more susceptible to long-term health issues such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more common with advancing age. Pharmaceuticals native starch offers benefits for chronic diseases by enhancing drug formulation stability, boosting bioavailability, enabling controlled drug release, supporting patient adherence, and ultimately strengthening the effectiveness and long-term management of chronic medical conditions. For instance, in April 2025, according to the Centers for Disease Control and Prevention, 76.4% of U.S. adults, representing approximately 194 million people, reported having one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the growing prevalence of chronic diseases is a key factor driving the pharmaceuticals native starch market. The expansion of generic drug manufacturing is anticipated to propel the growth of the pharmaceuticals native starch market in the future. Generic drug manufacturing refers to the production of off-patent medications that are biologically equivalent to their branded counterparts. This rise in generic drug manufacturing is attributed to increasing regulatory support that streamlines approvals and encourages more companies to produce affordable alternatives to branded medicines. The expansion of generic drug manufacturing supports pharmaceuticals native starch by increasing the demand for reliable, cost-effective excipients that improve tablet formulation, stability, and drug delivery efficiency across a broader range of high-volume generic medicines. For example, in November 2024, the Food and Drug Administration (FDA) reported that in FY 2023, the FDA approved 782 Abbreviated New Drug Applications (ANDAs), an increase from 722 approvals recorded in FY 2022. Consequently, the expansion of generic drug manufacturing is driving the growth of the pharmaceuticals native starch market.

Which Segment Types Are Examined In The Pharmaceuticals Native Starch Market Segment Study?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch

2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Which Trends Are Guiding The Direction Of The Pharmaceuticals Native Starch Market?

Leading companies in the pharmaceuticals native starch market are concentrating on developing innovative products, such as plant-based textures, to improve drug formulation and patient compliance. Plant-based texture refers to the physical characteristics derived from plant ingredients, like thickness and gel strength, and supports pharmaceutical applications of native starch by enhancing tablet binding, disintegration, and mouthfeel for better natural drug formulations. For example, in February 2024, Ingredion Incorporated, a US-based food company, introduced Novation Indulge 2940 starch, a clean-label texturizer formulated to boost texture and stability in dairy and alternative dairy products. This novel pharmaceutical native starch delivers functional properties that enhance drug formulation performance, bioavailability, and controlled release, concurrently supporting the creation of clean-label, sustainable products. The versatile NOVATION Indulge 2940 starch is an ingredient that improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, utilizing clean-label, natural ingredients.

Which Players Are Part Of The Competitive Landscape Of The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

Get The Full Pharmaceuticals Native Starch Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

Which Region Holds The Highest Market Share In The Pharmaceuticals Native Starch Market?

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmaceuticals Native Starch Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2026, By The Business Research Company

Modified Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/modified-starch-global-market-report

Industrial Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-starch-global-market-report

Starch Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/starch-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795